Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

Epithelial ovarian cancer is a fatal disease, with a cure rate of only 30%. Several recent studies have targeted integrins for cancer treatment. Preclinical studies have shown the effectiveness of several integrin inhibitors for blocking cancer progression, especially by blocking angiogenesis. Becau...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Masaki, Sawada, Kenjiro, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532619/
https://www.ncbi.nlm.nih.gov/pubmed/28698469
http://dx.doi.org/10.3390/cancers9070083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532619/
https://www.ncbi.nlm.nih.gov/pubmed/28698469
http://dx.doi.org/10.3390/cancers9070083

Ejemplares similares